Search Results

An Interview With Michael D. Dake, MD

A world leader in endoluminal treatment of aortic disease discusses the evolution of TAA grafting and the Zilver PTX trial.

By Michael D. Dake, MD

The Zilver PTX Global Registry and RCT

Michael D. Dake, MD, discusses the early experiences in the Zilver PTX randomized trial and the results seen in the larger global registry studying a paclitaxel-eluting stent in the SFA.

Insights on the DISSECT Classification System

Michael D. Dake, MD, describes the goals, details, and real-world applicability of a modern, mnemonic-based classification system for aortic dissection.

Perspective: Exploring Outpatient EVAR

Pipe dream or reality? With a new generation of low-profile devices emerging, Michael D. Dake, MD, shares his thoughts on the future of taking endovascular aneurysm repair to the outpatient setting.

Perspective: Exploring Outpatient EVAR

Pipe dream or reality? With a new generation of low-profile devices emerging, Michael D. Dake, MD, shares his thoughts on the future of taking endovascular aneurysm repair to the outpatient setting.

Advances in Treating Thoracic Aortic Dissection

By Matt M. Thompson, MD, FRCS, and Michael D. Dake, MD

Chronic Cerebrospinal Venous Insufficiency

A new paradigm and therapy for multiple sclerosis.

By Salvatore J.A. Sclafani, MD
Commentary by Michael D. Dake, MD,
and Barry T. Katzen, MD

One Question . . .

If you perform TEVAR to treat acute type B dissection, do you use IVUS during the procedure?

By Manish Mehta, MD; Ross Milner, MD; Michael D. Dake, MD; Edward Y. Woo, MD; and Firas F. Mussa, MD

Evaluating the Zilver PTX Stent

Principal investigators discuss the clinical study design and initial results with the Zilver PTX drug-eluting peripheral stent in the SFA.

By Michael D. Dake, MD; Gary M. Ansel, MD, FACC; and Anthony O. Ragheb, PHD

SFA Trials, Devices, and Decisions

An expert panel provides candid perspectives on issues facing current clinical trials and the regulatory environment, adopting new technologies, and daily decision making in busy peripheral practices.
Featuring Gary M. Ansel, MD, FACC; Michael D. Dake, MD; Lawrence A. Garcia, MD; John R. Laird, MD; and Peter A. Schneider, MD

An Algorithmic Strategy for the Evaluation and Management of Type B Dissections

An experience- and data-based approach to this challenging and diverse thoracic pathology.

By Michael D. Dake, MD

Roundtable Discussion: Venous Stenting Perspectives: Current Best Practices, Trial Experiences, and Device Designs

With Steven D. Abramowitz, MD; Stephen A. Black, MD, FRCS(Ed), FEBVS; Michael D. Dake, MD; Erin H. Murphy, MD, FACS; Gerard O'Sullivan, MD; and Mahmood K. Razavi, MD, FSIR, FSVM

Acute Type A Aortic Dissection

Moderator: Ali Azizzadeh, MD, FACS
Panel: Benjamin Jackson, MD, FACS; Joseph Bavaria, MD, FACS; Kristofer M. Charlton-Ouw, MD, FACS; Anthony L. Estrera, MD, FACS; Michael Fischbein, MD, PhD; Michael D. Dake, MD; and Jason T. Lee, MD

Early Experiences With Thoracic Branch Devices

A look at expanding endovascular solutions for complex aortic disease, highlighting next-generation thoracic branch systems, their design innovation and early clinical experience, and the evolving regulatory landscape.

With Michael D. Dake, MD; Adam W. Beck, MD, FACS; Carlos Timaran, MD; Giovanni Tinelli, MD, PhD; Simona Sica, MD; Yamume Tshomba, MD; Robert C. Lind, MD, PhD; and Jacob Budtz-Lilly, MD, PhD, FEBVS

Stent Fracture Resistance of a Cobalt Chromium Stent

Comparative studies are necessary to examine various devices' performance in the renal arteries.

By Mahmood K. Razavi, MD; Alexander Nikanorov, MD, PhD; H. Bob Smouse, MD; Hao-Ming Hsiao, PhD; and Michael D. Dake, MD